New China Life will wait to launch IPO after listing hearing
New China Life Insurance got approval from the Hong Kong listing committee on Thursday for a planned $4bn dual-listing in Hong Kong and Shanghai. But bankers close to the deal said it was unlikely to be launched for at least another week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts